Femasys, Inc. (FEMY)
1.67
-0.08
(-4.57%)
USD |
NASDAQ |
Oct 13, 09:44
Femasys Net Income (Quarterly) : -4.469M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.469M |
| March 31, 2026 | 0.3286M |
| December 31, 2025 | -3.950M |
| September 30, 2025 | -4.195M |
| June 30, 2025 | -4.586M |
| March 31, 2025 | -5.897M |
| December 31, 2024 | -5.124M |
| September 30, 2024 | -5.409M |
| June 30, 2024 | -4.685M |
| March 31, 2024 | -3.600M |
| December 31, 2023 | -4.410M |
| September 30, 2023 | -3.997M |
| June 30, 2023 | -2.894M |
| Date | Value |
|---|---|
| March 31, 2023 | -2.946M |
| December 31, 2022 | -2.894M |
| September 30, 2022 | -2.983M |
| June 30, 2022 | -2.634M |
| March 31, 2022 | -2.883M |
| December 31, 2021 | -2.365M |
| September 30, 2021 | -2.260M |
| June 30, 2021 | -1.083M |
| March 31, 2021 | -1.830M |
| December 31, 2020 | -1.660M |
| September 30, 2020 | -1.568M |
| June 30, 2020 | -1.486M |
| March 31, 2020 | -2.202M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Abbott Laboratories | 928.00M |
| AngioDynamics, Inc. | -7.097M |
| Alphatec Holdings, Inc. | -25.78M |
| AtriCure, Inc. | 8.955M |
| Baxter International, Inc. | 135.00M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.3318M |
| Total Expenses (Quarterly) | 4.801M |
| EPS Diluted (Quarterly) | -1.331 |
| Enterprise Value | 8.639M |
| Gross Profit Margin (Quarterly) | -2.41% |
| Profit Margin (Quarterly) | -1.35K% |
| Earnings Yield | -276.5% |
| Normalized Earnings Yield | -359.21 |